查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529766

止血閥市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區和細分市場預測，2024-2030 年

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type, By Application (Angiography, Angioplasty), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

止血閥市場規模及趨勢

2023年全球止血閥市場規模預估為1.748億美元，預估2024年至2030年複合年成長率為5.8%。心血管疾病盛行率的增加、支持性法律規範、老年人口的增加以及技術進步正在顯著推動市場成長。根據世界心臟聯盟2023年發布的報告，心血管疾病（CVD）在全球造成嚴重影響，影響全球超過5億人，預計2021年將增加到2,050萬人左右。這增加了對血管造影術和血管成形術等診斷和治療程序的需求，而止血閥對於控制血流和確保導管插入期間患者的安全至關重要。

對微創手術的偏好也是推動市場成長的關鍵因素。微創手術與傳統開放性手術相比具有許多優勢，包括減輕疼痛、縮短住院時間、加快復原時間和降低併發症風險。因此，對促進這些手術的醫療設備的需求不斷成長。止血閥對於微創導管介入至關重要，因為它們可以精確控制血流並防止手術過程中滲漏。心臟病學和其他醫療領域向微創技術的轉變正在推動止血閥的採用。

由於出生率下降和醫療進步導致預期壽命延長，世界人口結構正在經歷人口老化的顯著轉變。據世界衛生組織 (WHO) 稱，到 2050 年，全球 60 歲及以上的人口數量預計將增加一倍，達到約 21 億人。這種人口結構的變化凸顯了老年人與老齡化相關的疾病，包括心血管疾病（CVD）的盛行率不斷增加。根據美國心臟協會2023年11月發表的一篇論文，心臟衰竭是一種廣泛且多方面的心血管疾病，影響著超過670萬美國，尤其是在65歲及以上的老年人中很流行。人口老化更容易患心血管疾病，這正在推動對診斷和治療程序的需求並推動市場成長。

醫療設備的技術進步對於推動市場成長至關重要。材料、設計和功能方面的創新正在開發更有效、更可靠的止血閥。例如，先進聚合物和塗層的使用使這些設備更加耐用和生物相容性，減少血栓症和感染疾病等併發症。此外，易於使用的鎖定機構和增強的密封能力等新功能正在提高止血閥在臨床環境中的效率。例如，波士頓科學公司的 WATCHDOG 止血閥採用創新的十字縫設計，最大限度地減少洩漏，並具有可同時容納多個設備的 8F 內腔。此外，它還具有拇指休息功能，旨在增加手術過程中的舒適度。這些設計元素可減少失血和空氣栓塞的風險，在整個醫療過程中始終將病患安全放在首位。

被優先考慮。這些技術改進將使手術更安全、更有效率，並鼓勵止血閥的採用。

全球止血閥市場細分

該報告預測了2018年至2030年的收益成長情況，並分析了各個子區隔的最新趨勢。在本報告中，Grand View Research, Inc. 根據類型、應用、最終用途和地區對全球止血閥市場報告進行了細分。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章：止血閥市場的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 助劑市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業分析-波特五力分析
    • PESTEL分析
  • COVID-19對止血閥市場的影響
  • 價格分析

第4章止血閥市場：按類型估計和趨勢分析

  • 細分儀表板
  • 止血閥市場：類型變化分析，2023 年和 2030 年

第5章止血閥市場：按應用、估計和趨勢分析

  • 細分儀表板
  • 止血閥市場：2023 年和 2030 年應用變化分析

第6章止血閥市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 止血閥市場：2023 年和 2030 年最終用途變化分析

第7章止血閥市場：區域估計及趨勢分析

  • 2023 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2023年主要企業市場佔有率分析
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun Melsungen AG
    • TERUMO CORPORATION
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends

The global hemostasis valve market size was estimated at USD 174.8 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. According to the report published by World Heart Federation in 2023, cardiovascular diseases (CVDs) have a profound global impact, affecting over half a billion people worldwide and resulting in approximately 20.5 million deaths in 2021.This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. The shift towards minimally invasive techniques in cardiology and other medical fields drives the adoption of hemostasis valves.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medi

cal interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and regions.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID-19 on the Hemostasis Valve Market
  • 3.4. Pricing Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hemostasis Valve Market: Type Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Hemostasis Valve Y- Connectors
      • 4.2.1.1. Hemostasis Valve Y- Connectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Double Y - Connector Hemostasis Valves
      • 4.2.2.1. Double Y - Connector Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. One-Handed Hemostasis Valves
      • 4.2.3.1. One-Handed Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hemostasis Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Angiography
      • 5.2.1.1. Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Angioplasty
      • 5.2.2.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Angioplasty
      • 5.2.3.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hemostasis Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 6.2.1. Hospitals
      • 6.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Ambulatory Surgical Centers
      • 6.2.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Others
      • 6.2.3.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Boston Scientific Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Teleflex Incorporated
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Merit Medical Systems
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. TERUMO CORPORATION
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Argon Medical Devices
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Freudenberg Medical
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. SCW Medicath Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Nipro
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Type benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. DeRoyal Industries, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Type benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Antmed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Type benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Beijing Demax Medical Technology Co
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Type benchmarking
      • 8.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Hemostasis Valve Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 UK Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 UK Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 UK Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 France Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Italy Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Spain Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Norway Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Japan Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53 China Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 China Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 India Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 India Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Thailand Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Argentina Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Argentina Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Mexico Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hemostasis Valve market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Hemostasis valve market: Type movement analysis
  • Fig. 17 Hemostasis valve market: Type segment dashboard
  • Fig. 18 Hemostasis valve market Type outlook: Key takeaways
  • Fig. 19 Hemostasis valve Y- connectors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Double Y- Connector hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 One- Handed hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Tissue retractors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Hemostasis Valve market: Application movement analysis
  • Fig. 25 Hemostasis Valve market Application outlook: Key takeaways
  • Fig. 26 Angiography hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Angioplasty hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Hemostasis Valve market: End use movement analysis
  • Fig. 29 Hemostasis Valve market End use outlook: Key takeaways
  • Fig. 30 Hospitals Hemostasis Valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Regional market dashboard
  • Fig. 35 Regional market place: Key takeaways
  • Fig. 36 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 64 Heat map analysis
  • Fig. 65 Market differentiators